Injections or infusions diagnostic & therapeutic procedures G388 - Management of special oral chemotherapy, for malignant disease

General Info

Billing Amount: $0.00

Description

This is the service for the supervision of oral chemotherapy treatment for malignant disease where the agent(s) has a significant risk of toxicity in the period immediately following initiation. The physician must be available to intervene in a timely fashion for a 24 hour period following the initiation of the treatment. In addition to the Common Elements in this Schedule, this service includes the provision of the following services to the same patient: a. evaluation of any relevant laboratory, diagnostic and/or imaging investigations; and b. all discussion or advice, whether by telephone or otherwise, involving the patient, staff, patient’s relative(s) or patient’s representative related to the oral chemotharapy for a period of twenty-one (21) days following initiation of the agent(s).

Notes:

1. G388 is not eligible for payment for the same patient in the same month where G382 is payable.
2. G388 is only eligible for payment once every twenty-one (21) days to a maximum of six (6) services per patient per 12 month period.

Examples of special oral chemotherapy include fludarabine, imatinib, dasatanib, nilotinib, erlotinib, capecitabine, sunitinib, sorafenib, thalidomide, temazolamide and lenalidomide.